Status:
WITHDRAWN
Plantar Wart Treatment Using Adapalene Gel
Lead Sponsor:
University of Louisville
Conditions:
Plantar Wart
Eligibility:
All Genders
6-90 years
Phase:
EARLY_PHASE1
Brief Summary
This study seeks to research the efficacy of Adapalene 0.1% gel as a cost effective and low risk treatment option for plantar warts of the foot. Patients that present/diagnosed in designated clinics w...
Detailed Description
PROBLEM/BACKGROUND: Plantar warts are the result of a DNA virus called Human Papilloma Virus (HPV), specifically subtypes 1,2,4,27, and 57. Plantar warts are a common complaint among adults and childr...
Eligibility Criteria
Inclusion
- patients must be diagnosed with plantar warts
Exclusion
- pregnant women
- previous wart treatment within the last 2 weeks
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 10 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04823845
Start Date
May 1 2022
End Date
February 10 2023
Last Update
April 13 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.